Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Chen, Kaiyun ^a   Xia, Yong ^b   Wang, Hanning ^a   Xiao, Fanglian ^a   Xiang, Guoan ^a   Shen, Feng ^b  

^a GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FEMALE; HAIR LOSS; HEART ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LEUKOCYTE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RADIATION INDUCED EMESIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK REDUCTION; SIDE EFFECT; SINUS TACHYCARDIA; SUPRAVENTRICULAR PREMATURE BEAT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; VOMITING;

ADULT; BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS;

EID: 84874557696     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057397     Document Type: Article

References (35)

1. Lopez PM, Villanueva A, Llovet JM, (2006) Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23: 1535-1547.
2. Chang CH, Chau GY, Lui WY, Tsay SH, King KL, et al. (2004) Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 139: 320-325, 326.
3. Tung-Ping PR, Fan ST, Wong J, (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232: 10-24.
4. Lai EC, Lo CM, Fan ST, Liu CL, Wong J, (1998) Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 133: 183-188.
5. Takenaka K, Yoshida K, Nishizaki T, Korenaga D, Hiroshige K, et al. (1995) Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 169: 400-404, 405.
6. Lo CM, Liu CL, Chan SC, Lam CM, Poon RT, et al. (2007) A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 245: 831-842.
7. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, et al. (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356: 802-807.
8. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, et al. (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 334: 1561-1567.
9. Aronowitz JN, (2002) Buried emanation; the development of seeds for permanent implantation. Brachytherapy 1: 167-178.
10. Wuu CS, Kliauga P, Zaider M, Amols HI, (1996) Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources. Int J Radiat Oncol Biol Phys 36: 689-697.
11. Huang K, Sneed PK, Kunwar S, Kragten A, Larson DA, et al. (2009) Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol 91: 83-93.
12. Horwitz EM, Frazier AJ, Vicini FA, Clarke DH, Edmundson GK, et al. (1997) The impact of temporary iodine-125 interstitial implant boost in the primary management of squamous cell carcinoma of the oropharynx. Head Neck 19: 219-226.
13. Horwitz EM, Frazier AJ, Martinez AA, Keidan RD, Clarke DH, et al. (1996) Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost. Cancer 78: 948-957.
14. Goertz SR, Ali MM, Parker GA, (1990) Local management of pancreatic carcinoma: iodine-125 implantation. Clin Oncol (R Coll Radiol) 2: 22-26.
15. Son YH, Ariyan S, (1985) Intraoperative adjuvant radiotherapy for advanced cancers of the head and neck. Preliminary report. Am J Surg 150: 480-484.
16. Zhang FJ, Li CX, Wu PH, Wu YX, Jiao DC, et al. (2007) [CT guided radioactive 125I seed implantation in treating localized advanced pulmonary carcinoma]. Zhonghua Yi Xue Za Zhi 87: 3272-3275.
17. Heysek RV, (2007) Modern brachytherapy for treatment of prostate cancer. Cancer Control 14: 238-243.
18. Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester JE, et al. (1997) Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 80: 442-453.
19. Martinez-Monge R, Nag S, Nieroda CA, Martin EW, (1999) Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer 85: 1218-1225.
20. Armstrong JG, Anderson LL, Harrison LB, (1994) Treatment of liver metastases from colorectal cancer with radioactive implants. Cancer 73: 1800-1804.
21. Nag S, DeHaan M, Scruggs G, Mayr N, Martin EW, (2006) Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 64: 736-744.
22. Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP, (2003) Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197: 753-758.
23. Covey AM, Maluccio MA, Schubert J, BenPorat L, Brody LA, et al. (2006) Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer 106: 2181-2189.
24. Lau WY, Leung TW, Ho SK, Chan M, Machin D, et al. (1999) Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 353: 797-801.
25. Sun HC, Tang ZY, Wang L, Qin LX, Ma ZC, et al. (2006) Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol 132: 458-465.
26. Schwartz JD, Schwartz M, Mandeli J, Sung M, (2002) Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 3: 593-603.
27. Ono T, Yamanoi A, Nazmy EAO, Kohno H, Nagasue N, (2001) Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer 91: 2378-2385.
28. Samuel M, Chow PK, Chan SE, Machin D, Soo KC (2009) Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev: D1199.
29. Joyce F, Burcharth F, Holm HH, Stroyer I, (1990) Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys 19: 1049-1052.
30. Chuan-Xing L, Xu H, Bao-Shan H, Yong L, Pei-Jian S, et al. (2011) Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed. Cancer Biol Ther 12: 865-871.
31. Luo J, Yan Z, Liu Q, Qu X, Wang J, (2011) Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein. J Vasc Interv Radiol 22: 479-489.
32. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, et al. (1995) Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 22: 209-234.
33. Strasser-Wozak EM, Hartmann BL, Geley S, Sgonc R, Bock G, et al. (1998) Irradiation induces G2/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expression. Cell Death Differ 5: 687-693.
34. Zhuang HQ, Wang JJ, Liao AY, Wang JD, Zhao Y, (2009) The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells. J Exp Clin Cancer Res 28: 12.
35. Xiang GA, Chen KY, Wang HN, Xiao JF, (2010) [Immunological influence of iodine-125 implantation in patients with hepatocellular carcinoma resection]. Nan Fang Yi Ke Da Xue Xue Bao 30: 292-294.